Cancer Imaging With Fluorine-18–Labeled Choline Derivatives

Katz-Brull, 1996, Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method, Anticancer Res, 16, 1375

Nakagami, 1999, Increased choline kinase activity and elevated phosphocholine levels in human colon cancer, Jpn J Cancer Res, 90, 419, 10.1111/j.1349-7006.1999.tb00764.x

Ramirez de Molina, 2002, Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers, Biochem Biophys Res Commun, 296, 580, 10.1016/S0006-291X(02)00920-8

Hara, 1998, PET imaging of prostate cancer using carbon-11-choline, J Nucl Med, 39, 990

Hara, 1997, PET imaging of brain tumor with [methyl-11C]choline, J Nucl Med, 38, 842

Yoshida, 2006, C-choline positron emission tomography in bladder cancer: report of four cases, Int J Urol, 13, 829, 10.1111/j.1442-2042.2006.01416.x

Picchio, 2006, Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: Correlation with histopathologic findings, J Nucl Med, 47, 938

Gofrit, 2006, Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma, J Urol, 176, 940, 10.1016/j.juro.2006.04.018

Farsad, 2005, Detection and localization of prostate cancer: Correlation of (11)C-choline PET/CT with histopathologic step-section analysis, J Nucl Med, 46, 1642

de Jong, 2002, Visualization of prostate cancer with 11C-choline positron emission tomography, Eur Urol, 42, 18, 10.1016/S0302-2838(02)00129-X

de Jong, 2002, Visualisation of bladder cancer using (11)C-choline PET: First clinical experience, Eur J Nucl Med Mol Imaging, 29, 1283, 10.1007/s00259-002-0881-7

Hara, 2002, Development of (18)F-fluoroethylcholine for cancer imaging with PET: Synthesis, biochemistry, and prostate cancer imaging, J Nucl Med, 43, 187

DeGrado, 2001, Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: Initial findings in prostate cancer, Cancer Res, 61, 110

Bansal, 2006, Biodisposition and Metabolism of [18F]fluorocholine in cultured 9L glioma cells and subcutaneous 9L tumor model, Mol Imaging Biol, 8, 78

Gilissen, 2003, Evaluation of 18F-FA-4 and 11C-pipzA-4 as radioligands for the in vivo evaluation of the high-affinity choline uptake system, J Nucl Med, 44, 269

Hara, 2006, Choline transporter as a novel target for molecular imaging of cancer, Mol Imaging, 5, 498, 10.2310/7290.2006.00032

Spaeth, 2004, Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: Implications for separation of radiation necrosis from tumor recurrence, J Nucl Med, 45, 1931

DeGrado, 2001, Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers, J Nucl Med, 42, 1805

Iwata, 2002, [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: Preparation and application to the on-column preparation of [18F]fluorocholine, Appl Radiat Isot, 57, 347, 10.1016/S0969-8043(02)00123-9

Lim, 2003, Automated production of[18F]FECh and [18F]FCH: Preparation and use of [18F]fluoroalkane sulfonates and fluoroalkylation agents, J. Label Compd Radiopharm, 46, S403

Hara, 2001, 18F-fluorocholine: A new oncologic PET tracer, J Nucl Med, 42, 1815

Cuadrado, 1993, Phosphorylcholine: A novel second messenger essential for mitogenic activity of growth factors, Oncogene, 8, 2959

Breeuwsma, 2005, In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer, Eur J Nucl Med Mol Imaging, 32, 668, 10.1007/s00259-004-1741-4

Glunde, 2006, Choline metabolism in cancer: Implications for diagnosis and therapy, Expert Rev Mol Diagn, 6, 821, 10.1586/14737159.6.6.821

Yamaguchi, 2005, Prostate cancer: A comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy, Eur J Nucl Med Mol Imaging, 32, 742, 10.1007/s00259-004-1755-y

Kwee, 2004, Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation, J Neuroimaging, 14, 285, 10.1111/j.1552-6569.2004.tb00253.x

Padma, 2005, Functional imaging of a large demyelinating lesion, J Clin Neurosci, 12, 176, 10.1016/j.jocn.2004.02.024

Kohli V KS, Coel MN. Comparison between 2D and 3D Prostate PET Imaging. J Nucl Med 2006;46:370P.

Schoder, 2004, Positron emission tomography for prostate, bladder, and renal cancer, Semin Nucl Med, 34, 274, 10.1053/j.semnuclmed.2004.06.004

Shreve, 1996, Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose, Radiology, 199, 751, 10.1148/radiology.199.3.8638000

Price, 2002, Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer, J Urol, 168, 273, 10.1016/S0022-5347(05)64906-3

Basillote, 2003, Influence of prostate volume in the detection of prostate cancer, Urology, 61, 167, 10.1016/S0090-4295(02)02103-9

Naughton, 2000, A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection, J Urol, 164, 388, 10.1016/S0022-5347(05)67367-3

Kwee, 2005, Prostate cancer localization with 18fluorine fluorocholine positron emission tomography, J Urol, 173, 252, 10.1097/01.ju.0000142099.80156.85

Kwee, 2006, Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET, J Nucl Med, 47, 262

Schmid, 2005, Fluorocholine PET/CT in patients with prostate cancer: Initial experience, Radiology, 235, 623, 10.1148/radiol.2352040494

Talbot, 2006, PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: Preliminary comparison with [(18)F]FDG PET/CT, Eur J Nucl Med Mol Imaging, 33, 1285, 10.1007/s00259-006-0164-9

Heinisch, 2006, Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: Meaningful at PSA < 5 ng/ml?, Mol Imaging Biol, 8, 43, 10.1007/s11307-005-0023-2

Cimitan, 2006, [(18)F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: Experience in 100 consecutive patients, Eur J Nucl Med Mol Imaging, 33, 1387, 10.1007/s00259-006-0150-2

Langsteger, 2006, The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast, Semin Nucl Med, 36, 73, 10.1053/j.semnuclmed.2005.09.002

Martorana, 2006, 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy, J Urol, 176, 954, 10.1016/j.juro.2006.04.015

Kwee, 2007, Solitary brain lesions enhancing at MR imaging: Evaluation with fluorine 18 fluorocholine PET, Radiology, 244, 557, 10.1148/radiol.2442060898

Ohtani, 2001, Brain tumour imaging with carbon-11 choline: Comparison with FDG PET and gadolinium-enhanced MR imaging, Eur J Nucl Med, 28, 1664, 10.1007/s002590100620

Goebell, 2006, Low-grade and anaplastic gliomas: Differences in architecture evaluated with diffusion-tensor MR imaging, Radiology, 239, 217, 10.1148/radiol.2383050059

Provenzale, 2004, Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging, Radiology, 232, 451, 10.1148/radiol.2322030959

Burtscher, 2000, Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings, AJNR Am J Neuroradiol, 21, 84

Vesselle, 1998, FDG PET of the retroperitoneum: Normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls, Radiographics, 18, 805, 10.1148/radiographics.18.4.9672967

Wang, 2006, [Value of carbon-11 choline positron emission tomography in patients with pulmonary abnormalities], Zhonghua Wai Ke Za Zhi, 44, 405

Roivainen, 2003, Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium, Arthritis Rheum, 48, 3077, 10.1002/art.11282

Sasaki, 2004, [11C]choline uptake in regenerating liver after partial hepatectomy or CCl4-administration, Nucl Med Biol, 31, 269, 10.1016/j.nucmedbio.2003.07.001

Kubota, 2006, Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation, Ann Nucl Med, 20, 527, 10.1007/BF03026816

Wyss, 2004, 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET, Eur J Nucl Med Mol Imaging, 31, 312, 10.1007/s00259-003-1337-4